HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

PLZ4 peptide

binds bladder cancer cells

Also Known As:

cQDGRMGFc; cyclo(Asn-Asp-Gly-Arg-Met-Gly-Phe); cyclo(asparagyl-aspartyl-glycyl-arginyl-methionyl-glycyl-phenylalanyl)

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - PLZ4 peptide: 1
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - PLZ4 peptide: 1

Experts

1.	Aina, Olulanu H: 1 article (09/2012)
2.	Bassuk, James A: 1 article (09/2012)
3.	Evans, Christopher: 1 article (09/2012)
4.	Henderson, Paul: 1 article (09/2012)
5.	Lam, Kit S: 1 article (09/2012)
6.	Lara, Primo N: 1 article (09/2012)
7.	Pan, Chong-Xian: 1 article (09/2012)
8.	Wang, Xiaobing: 1 article (09/2012)
9.	Zhang, Hongyong: 1 article (09/2012)
10.	de Vere White, Ralph: 1 article (09/2012)

Related Diseases

1.	Urinary Bladder Neoplasms (Bladder Cancer) 09/01/2012 - "One cyclic peptide named PLZ4 (amino acid sequence: cQDGRMGFc) was identified that could selectively bind to bladder cancer cell lines and all of the 5 primary bladder cancer cells from human patients, but not to normal urothelial cells, cell mixtures from normal bladder specimens, fibroblasts, and blood cells. "

Related Drugs and Biologics

1.	Cyclic Peptides